MinichMacGregor Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

MinichMacGregor Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-199	Closed	-$1.81K	–	588
2022 Q4	$1.81K	Buy	+199	New	+$1.74K	﹤0.01%	572
2018 Q4	–	Sell	-199	Closed	-$4K	–	471
2018 Q3	$4K	Hold	199	–	–	﹤0.01%	414
2018 Q2	$4K	Hold	199	–	–	﹤0.01%	409
2018 Q1	$3K	Hold	199	–	–	﹤0.01%	411
2017 Q4	$3K	Sell	199 -7	-3%	-$105	﹤0.01%	401
2017 Q3	$3K	Hold	206	–	–	﹤0.01%	384
2017 Q2	$6K	Hold	206	–	–	0.01%	341
2017 Q1	$6K	Hold	206	–	–	0.01%	336
2016 Q4	$7K	Hold	206	–	–	0.01%	317
2016 Q3	$9K	Hold	206	–	–	0.01%	284
2016 Q2	$10K	Hold	206	–	–	0.01%	259
2016 Q1	$11K	Hold	206	–	–	0.01%	239
2015 Q4	$12K	Buy	+206	New	+$12.7K	0.01%	216

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MinichMacGregor Wealth Management's TEVA Position: Q1 2023 in Review

MinichMacGregor Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2023, closing a stake of 199 shares — an estimated $1.81K sold.

MinichMacGregor Wealth Management first reported a position in TEVA in Q4 2015 and held it in 13 quarters. The position peaked at $12K in Q4 2015. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2023.

MinichMacGregor Wealth Management reported no remaining Teva Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
MinichMacGregor Wealth Management sold 199 Teva Pharmaceuticals shares in Q1 2023, an estimated $1.81K.
MinichMacGregor Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 13 quarters.
MinichMacGregor Wealth Management's Teva Pharmaceuticals position peaked at $12K in Q4 2015.
438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.